160 related articles for article (PubMed ID: 26958158)
1. An Interactive User Interface for Drug Labeling to Improve Readability and Decision-Making.
Abedtash H; Duke JD
AMIA Annu Symp Proc; 2015; 2015():278-86. PubMed ID: 26958158
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
[TBL] [Abstract][Full Text] [Related]
3. Harnessing scientific literature reports for pharmacovigilance. Prototype software analytical tool development and usability testing.
Sorbello A; Ripple A; Tonning J; Munoz M; Hasan R; Ly T; Francis H; Bodenreider O
Appl Clin Inform; 2017 Mar; 8(1):291-305. PubMed ID: 28326432
[TBL] [Abstract][Full Text] [Related]
4. Review of FDA Amendments Act Section 921 Experience in Posting Data-mining Results from the FAERS Database.
Beninger P; Murray M
Clin Ther; 2021 Feb; 43(2):380-395. PubMed ID: 33504449
[TBL] [Abstract][Full Text] [Related]
5. Integrating Regulatory Drug Label Information to Facilitate Evaluation of Adverse Events in Pharmacovigilance.
Hui TZ
Curr Drug Saf; 2020; 15(2):124-130. PubMed ID: 32091345
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
7. Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.
Karapetiantz P; Audeh B; Redjdal A; Tiffet T; Bousquet C; Jaulent MC
J Med Internet Res; 2024 Jun; 26():e46176. PubMed ID: 38888956
[TBL] [Abstract][Full Text] [Related]
8. A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.
Hoffman KB; Dimbil M; Tatonetti NP; Kyle RF
Drug Saf; 2016 Jun; 39(6):561-75. PubMed ID: 26946292
[TBL] [Abstract][Full Text] [Related]
9. Can social media data lead to earlier detection of drug-related adverse events?
Duh MS; Cremieux P; Audenrode MV; Vekeman F; Karner P; Zhang H; Greenberg P
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1425-1433. PubMed ID: 27601271
[TBL] [Abstract][Full Text] [Related]
10. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
Stobaugh DJ; Deepak P; Ehrenpreis ED
J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
[TBL] [Abstract][Full Text] [Related]
11. The Internet and drug safety: what are the implications for pharmacovigilance?
Cobert B; Silvey J
Drug Saf; 1999 Feb; 20(2):95-107. PubMed ID: 10082068
[TBL] [Abstract][Full Text] [Related]
12. Standardisation of the FAERS database: a systematic approach to manually recoding drug name variants.
Wong CK; Ho SS; Saini B; Hibbs DE; Fois RA
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):731-7. PubMed ID: 26017154
[TBL] [Abstract][Full Text] [Related]
13. Consistency in the safety labeling of bioequivalent medications.
Duke J; Friedlin J; Li X
Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):294-301. PubMed ID: 23042584
[TBL] [Abstract][Full Text] [Related]
14. Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events.
Wang K; Wan M; Wang RS; Weng Z
J Med Internet Res; 2016 Apr; 18(4):e76. PubMed ID: 27036325
[TBL] [Abstract][Full Text] [Related]
15. Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance?
Bagheri H; Lacroix I; Guitton E; Damase-Michel C; Montastruc JL
Therapie; 2016 Apr; 71(2):235-9. PubMed ID: 27080844
[TBL] [Abstract][Full Text] [Related]
16. Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions.
Li Y; Jimeno Yepes A; Xiao C
Drug Saf; 2020 Sep; 43(9):893-903. PubMed ID: 32385840
[TBL] [Abstract][Full Text] [Related]
17. Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial.
McCormack L; Craig Lefebvre R; Bann C; Taylor O; Rausch P
Drug Saf; 2016 Feb; 39(2):171-84. PubMed ID: 26547718
[TBL] [Abstract][Full Text] [Related]
18. [Direct reporting by patients of adverse drug reactions in Spain].
Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
[TBL] [Abstract][Full Text] [Related]
19. A comparison of decision and timing of safety related labeling changes for new drugs approved both in Japan and the United States.
Hoshino Y; Narukawa M
Pharmacoepidemiol Drug Saf; 2021 May; 30(5):561-572. PubMed ID: 33559352
[TBL] [Abstract][Full Text] [Related]
20. Automatic detection of adverse events to predict drug label changes using text and data mining techniques.
Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
